|
|
|
Size
|
Mary-Ann Sanfacon/CUSM/Reg06/SSSS is out of the office.
|
Mary-Ann Sanfacon |
Sun, 1 Jul 2012 01:01:42 -0400 |
97 lines |
Re: Movement of secure data
|
Webster Craig |
Sun, 1 Jul 2012 16:05:40 +0000 |
151 lines |
SURVEY: Enhancing pathology reporting through eConsultation
|
Richard Jones [Pathology] |
Mon, 2 Jul 2012 14:23:42 +0100 |
60 lines |
Re: Movement of secure data
|
Richard Jones [Pathology] |
Mon, 2 Jul 2012 15:52:35 +0100 |
179 lines |
FW: SURVEY: Enhancing pathology reporting through eConsultation
|
Richard Jones [Pathology] |
Tue, 3 Jul 2012 08:45:05 +0100 |
78 lines |
Unusual specimen types (continued)
|
Jonathan Kay |
Tue, 3 Jul 2012 09:06:22 +0000 |
67 lines |
Octreotide Suppression Test - how to interpret
|
Kelly Mitchem (Cwm Taf NHS Trust - Pathology) |
Wed, 4 Jul 2012 13:54:08 +0100 |
209 lines |
Re: Octreotide Suppression Test - how to interpret
|
Mohammed El Sammak |
Wed, 4 Jul 2012 14:37:51 +0100 |
8914 lines |
reverse T3
|
Caroline Addison |
Wed, 4 Jul 2012 14:44:49 +0100 |
34 lines |
Re: Octreotide Suppression Test - how to interpret
|
Dave Halsall |
Wed, 4 Jul 2012 14:53:24 +0100 |
93 lines |
Transient hypercalcaemic crisis
|
Mohammad Al-Jubouri |
Wed, 4 Jul 2012 07:07:44 -0700 |
97 lines |
Technology Stategy Board project in pathology testing - statistician and modeller posts advertised
|
Richard Jones [Pathology] |
Wed, 4 Jul 2012 15:24:16 +0100 |
2095 lines |
‘I’m a Scientist, Get me out of Here!’
|
Jonathan Kay |
Thu, 5 Jul 2012 11:48:32 +0000 |
68 lines |
Attn Abbott users
|
Maria Fitzgibbon |
Thu, 5 Jul 2012 16:45:11 +0100 |
176 lines |
Re: Attn Abbott users
|
Miller,James J. |
Thu, 5 Jul 2012 17:32:59 +0000 |
139 lines |
Amost Friday
|
David Bullock |
Thu, 5 Jul 2012 20:02:04 +0100 |
46 lines |
Base Excess Calculation
|
Robert Lord |
Thu, 5 Jul 2012 21:04:48 +0100 |
33 lines |
Spuriously high D-dimer concentration
|
Steiner, Michael |
Thu, 5 Jul 2012 20:16:40 +0000 |
241 lines |
Re: reverse T3
|
Mohmed Ashmaig |
Thu, 5 Jul 2012 13:56:41 -0700 |
212 lines |
Important scientific announcement!
|
Jonathan Middle |
Thu, 5 Jul 2012 23:55:26 +0100 |
62 lines |
Re: Attn Abbott users
|
Blennerhassett, John |
Fri, 6 Jul 2012 09:57:56 +0800 |
620 lines |
Re: Attn Abbott users
|
Mainwaring-Burton Richard (SOUTH LONDON HEALTHCARE NHS TRUST) |
Fri, 6 Jul 2012 09:10:00 +0100 |
320 lines |
Doumas Bilirubin
|
birminghamquality |
Fri, 6 Jul 2012 11:26:55 +0100 |
226 lines |
Re: Attn Abbott users
|
COLLINS MICHAEL (RM1) Norfolk and Norwich University Hospital |
Fri, 6 Jul 2012 11:54:26 +0000 |
478 lines |
The safety implications of missed test results for hospitalised patients
|
Jonathan Kay |
Fri, 6 Jul 2012 17:18:29 +0100 |
89 lines |
Has anyone had any experiencePOCT Certest Faecal Calprotectin distributed by Launch in UK?
|
Darren Ames |
Sat, 7 Jul 2012 08:51:01 +0100 |
120 lines |
FW: Link to final version of 'Guidance for notified bodies on the regulation of IVDs for self-testing'
|
Freedman Danielle (RC9) Luton & Dunstable Hospital TR |
Sun, 8 Jul 2012 11:16:25 +0100 |
427 lines |
Re: Octreotide Suppression Test - how to interpret
|
PM CLARK |
Sun, 8 Jul 2012 15:13:38 +0100 |
265 lines |
SURVEY: Enhancing pathology reporting through eConsultation - gentle reminder
|
Richard Jones [Pathology] |
Mon, 9 Jul 2012 11:23:35 +0100 |
62 lines |
Re: Has anyone had any experiencePOCT Certest Faecal Calprotectin distributed by Launch in UK?
|
Bart Ballieux |
Mon, 9 Jul 2012 11:15:38 +0000 |
247 lines |
Serum/Plasma GLP1
|
Barlow Ian (NORTHERN LINCOLNSHIRE AND GOOLE HOSPITALS NHS FOUNDATION TRUST) |
Mon, 9 Jul 2012 14:30:38 +0100 |
189 lines |
Re: The safety implications of missed test results for hospitalised patients
|
Jonathan Kay |
Mon, 9 Jul 2012 14:59:00 +0100 |
131 lines |
Re: The safety implications of missed test results for hospitalised patients
|
OConnor John (ROYAL DEVON AND EXETER NHS FOUNDATION TRUST) |
Mon, 9 Jul 2012 16:10:41 +0100 |
411 lines |
Re: The safety implications of missed test results for hospitalised patients
|
John Francis Doran (ABM ULHB - Biochemistry) |
Mon, 9 Jul 2012 16:29:03 +0100 |
619 lines |
low HbA1c
|
Jeffrey Barron |
Tue, 10 Jul 2012 16:12:37 +1200 |
194 lines |
Re: low HbA1c
|
Bart Ballieux |
Tue, 10 Jul 2012 07:40:54 +0000 |
278 lines |
Reference ranges on NNU Blood gas analyser
|
Ford Clare (THE ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST) |
Tue, 10 Jul 2012 15:48:31 +0100 |
227 lines |
Abbott Optium Xceed vs. Menarini GlucoMen LX Plus POC ketone meters
|
Connell Emma (CROYDON HEALTH SERVICES NHS TRUST) |
Tue, 10 Jul 2012 15:54:01 +0100 |
186 lines |
Quality Indicators
|
JENNIFER GLAYSHER |
Tue, 10 Jul 2012 16:28:08 +0000 |
159 lines |
FW: diagnostic workshop
|
Rita Horvath |
Wed, 11 Jul 2012 14:55:37 +1000 |
601 lines |
Non-hospital members
|
David Hardy |
Wed, 11 Jul 2012 11:42:25 +0100 |
36 lines |
Salivary cortisol
|
Miller,James J. |
Wed, 11 Jul 2012 12:05:30 +0000 |
117 lines |
Non-Hospital members
|
David Hardy |
Wed, 11 Jul 2012 14:54:37 +0100 |
48 lines |
Units for timed urine collections
|
Henderson Rachel |
Wed, 11 Jul 2012 14:20:40 +0000 |
194 lines |
Waste disposal
|
Hogan, Tim |
Wed, 11 Jul 2012 16:56:06 +0000 |
192 lines |
Diabetes checks 'should be available in job centres'
|
Jonathan Kay |
Thu, 12 Jul 2012 07:14:03 +0000 |
68 lines |
Re: Diabetes checks 'should be available in job centres'
|
Jonathan Kay |
Thu, 12 Jul 2012 08:02:50 +0000 |
137 lines |
OCS order monitoring
|
JONES Stuart (Pathology) (RF4) BHR Hospitals |
Thu, 12 Jul 2012 08:49:39 +0000 |
212 lines |
Re: 2012 Order Comms survey
|
James Logie |
Thu, 12 Jul 2012 12:23:12 +0100 |
56 lines |
Re: Diabetes checks 'should be available in job centres'
|
Mainwaring-Burton Richard (SOUTH LONDON HEALTHCARE NHS TRUST) |
Thu, 12 Jul 2012 12:44:57 +0100 |
333 lines |
UK NEQAS [Edinburgh] - Vacancy and EQAS 2012!
|
Dr Cathie Sturgeon |
Thu, 12 Jul 2012 15:05:06 +0100 |
48 lines |
Dexamethasone
|
Cornes Michael (THE ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST) |
Thu, 12 Jul 2012 17:27:10 +0100 |
320 lines |
Re: Dexamethasone
|
Jonathan Kay |
Thu, 12 Jul 2012 17:29:43 +0100 |
280 lines |
Re: The safety implications of missed test results for hospitalised patients
|
Jonathan Kay |
Thu, 12 Jul 2012 17:37:18 +0100 |
174 lines |
Re: Dexamethasone
|
Webster Craig |
Thu, 12 Jul 2012 16:39:29 +0000 |
107 lines |
The safety implications of missed test results for hospitalised patients
|
Jonathan Kay |
Thu, 12 Jul 2012 17:40:34 +0100 |
46 lines |
Re: The safety implications of missed test results for hospitalised patients
|
Jeff Slater |
Thu, 12 Jul 2012 22:50:54 +0100 |
97 lines |
Re: The safety implications of missed test results for hospitalised patients
|
Rita Horvath |
Fri, 13 Jul 2012 10:10:24 +1000 |
2082 lines |
delta ckecks and critical limits for call-out of results
|
Ryan, Michael |
Fri, 13 Jul 2012 14:13:45 +0100 |
58 lines |
Siemens DCA Vantage
|
Czarnota, Alison |
Fri, 13 Jul 2012 16:09:05 +0100 |
179 lines |
Re: delta ckecks and critical limits for call-out of results
|
Jonathan Kay |
Fri, 13 Jul 2012 20:08:50 +0000 |
51 lines |
Predisolone assay availability in Australia
|
Douglas Chesher |
Mon, 16 Jul 2012 16:32:04 +1000 |
39 lines |
Bilirubin glucuronide
|
Clayton Jonathan (WIRRAL UNIVERSITY TEACHING HOSPITAL NHS FOUNDATION TRUST) |
Mon, 16 Jul 2012 15:57:31 +0100 |
198 lines |
Celiac sample
|
Mohmed Ashmaig |
Mon, 16 Jul 2012 09:06:49 -0700 |
63 lines |
Re: Bilirubin glucuronide
|
Rita Horvath |
Tue, 17 Jul 2012 08:23:35 +1000 |
118 lines |
POCT Equipment evaluation
|
Paula Marchetti |
Tue, 17 Jul 2012 09:27:22 +0100 |
104 lines |
B-cryptoxanthin
|
Dave Halsall |
Tue, 17 Jul 2012 09:36:13 +0100 |
26 lines |
Re: B-cryptoxanthin
|
Jonathan Kay |
Tue, 17 Jul 2012 08:45:25 +0000 |
43 lines |
Re: delta ckecks and critical limits for call-out of results
|
Macdonald Derek (NHS HIGHLAND) |
Tue, 17 Jul 2012 11:42:33 +0100 |
110 lines |
Patient access to clinical records
|
Richard Jones [Pathology] |
Tue, 17 Jul 2012 12:45:18 +0100 |
33 lines |
Insulin and haemolysis
|
Rachel Still (ABM ULHB - Chemical Pathology) |
Tue, 17 Jul 2012 14:07:57 +0100 |
205 lines |
Demand managing GP's
|
OConnor John (ROYAL DEVON AND EXETER NHS FOUNDATION TRUST) |
Wed, 18 Jul 2012 12:43:09 +0100 |
159 lines |
template for an SLA
|
Hogan, Tim |
Wed, 18 Jul 2012 13:45:58 +0000 |
182 lines |
Cobas bicarbonate method
|
[log in to unmask] |
Wed, 18 Jul 2012 16:58:10 +0100 |
30 lines |
Re: Demand managing GP's
|
Jonathan Kay |
Wed, 18 Jul 2012 17:13:49 +0000 |
178 lines |
Re: Demand managing GP's
|
Ian Young |
Wed, 18 Jul 2012 18:23:09 +0100 |
285 lines |
Re: Demand managing GP's
|
Fryer, Anthony (RJE) UHNS |
Thu, 19 Jul 2012 08:51:57 +0100 |
661 lines |
Benchmarking GP requesting profiles
|
Soha Zouwail |
Thu, 19 Jul 2012 09:11:18 +0100 |
45 lines |
Re: Demand managing GP's
|
OConnor John (ROYAL DEVON AND EXETER NHS FOUNDATION TRUST) |
Thu, 19 Jul 2012 09:15:30 +0100 |
826 lines |
Re: Benchmarking GP requesting profiles
|
Jonathan Kay |
Thu, 19 Jul 2012 08:18:22 +0000 |
66 lines |
Re: Demand managing GPs
|
Jonathan Kay |
Thu, 19 Jul 2012 08:25:25 +0000 |
955 lines |
Re: Demand managing GPs
|
OConnor John (ROYAL DEVON AND EXETER NHS FOUNDATION TRUST) |
Thu, 19 Jul 2012 09:37:23 +0100 |
1226 lines |
Demand management
|
Soha Zouwail |
Thu, 19 Jul 2012 09:37:34 +0100 |
30 lines |
Re: Demand managing GPs
|
Jonathan Kay |
Thu, 19 Jul 2012 08:46:26 +0000 |
253 lines |
Re: Demand management
|
Jonathan Kay |
Thu, 19 Jul 2012 08:50:20 +0000 |
120 lines |
Mythbusting sports and exercise products
|
Jonathan Kay |
Thu, 19 Jul 2012 09:20:50 +0000 |
68 lines |
Re: Mythbusting sports and exercise products
|
OConnor John (ROYAL DEVON AND EXETER NHS FOUNDATION TRUST) |
Thu, 19 Jul 2012 10:26:30 +0100 |
251 lines |
Re: Mythbusting sports and exercise products
|
Jonathan Kay |
Thu, 19 Jul 2012 11:51:39 +0000 |
222 lines |
FW: Advice needed on retention of records relating to POCT
|
Tilbrook Louise (MID ESSEX HOSPITAL SERVICES NHS TRUST) |
Thu, 19 Jul 2012 14:03:04 +0100 |
196 lines |
chain of custody - urine drug screens
|
Louise Ward |
Thu, 19 Jul 2012 17:16:37 +0100 |
191 lines |
Re: chain of custody - urine drug screens
|
Jonathan Kay |
Thu, 19 Jul 2012 16:19:31 +0000 |
161 lines |
FW: chain of custody - urine drug screens
|
Helen_Vangikar |
Thu, 19 Jul 2012 18:08:13 +0100 |
340 lines |
Re: chain of custody - urine drug screens
|
Simon Walker |
Thu, 19 Jul 2012 19:03:36 +0000 |
632 lines |
Re: chain of custody - urine drug screens
|
David James |
Fri, 20 Jul 2012 07:30:30 +0000 |
275 lines |
Re: chain of custody - urine drug screens
|
Morrell, Christine (DHSSC - DPHHP HPG Scientific Officer) |
Fri, 20 Jul 2012 08:44:54 +0100 |
373 lines |
Re: chain of custody - urine drug screens
|
John Christofides |
Fri, 20 Jul 2012 09:29:01 +0100 |
376 lines |
Cobas Bicarb
|
[log in to unmask] |
Fri, 20 Jul 2012 12:45:59 +0100 |
32 lines |
ACE measurements in uveitis
|
[log in to unmask] |
Fri, 20 Jul 2012 12:49:52 +0100 |
32 lines |
Re: Demand management
|
Webster Craig |
Fri, 20 Jul 2012 13:27:34 +0000 |
79 lines |
Lithium on Olympus AU analyzer
|
Steiner, Michael |
Fri, 20 Jul 2012 13:41:09 +0000 |
271 lines |
Re: chain of custody - urine drug screens
|
Rose Djiana |
Fri, 20 Jul 2012 15:29:19 -0400 |
90 lines |
Watson & Crick
|
Allan Gaw |
Mon, 23 Jul 2012 22:42:40 +0100 |
41 lines |
Re: Watson & Crick
|
David Bullock |
Mon, 23 Jul 2012 23:19:30 +0100 |
39 lines |
Posters at EQAS 2012 - Heriot-Watt Conference Centre - Edinburgh - September 24-26th 2012
|
Dr Cathie Sturgeon |
Tue, 24 Jul 2012 05:32:34 +0100 |
108 lines |
Useful and free resource for trainees in clinical chemistry
|
Rita Horvath |
Wed, 25 Jul 2012 14:58:14 +1000 |
9189 lines |
pregnancy related reference ranges - Roche systems
|
Anderson Julia (NHS DUMFRIES & GALLOWAY) |
Wed, 25 Jul 2012 11:42:19 +0100 |
137 lines |
KIM-1
|
Soha Zouwail |
Wed, 25 Jul 2012 12:08:19 +0100 |
37 lines |
Randox Analysers
|
Elizabeth MacNamara, Dr. |
Wed, 25 Jul 2012 11:20:07 +0000 |
34 lines |
Anti-muscarinic antibodies
|
Hanton Sally (AINTREE UNIVERSITY HOSPITAL NHS FOUNDATION TRUST) |
Wed, 25 Jul 2012 13:38:15 +0100 |
145 lines |
Re: Anti-muscarinic antibodies
|
Jonathan Kay |
Wed, 25 Jul 2012 14:04:50 +0100 |
171 lines |
Substance p
|
Emma Walker |
Thu, 26 Jul 2012 10:18:24 +0100 |
38 lines |
Testing for Sjogren-Larsson syndrome
|
Armer Jane (LTHTR) |
Thu, 26 Jul 2012 13:44:01 +0000 |
210 lines |
Re: Testing for Sjogren-Larsson syndrome
|
Jonathan Kay |
Thu, 26 Jul 2012 14:53:07 +0100 |
246 lines |
urine handling
|
Mainwaring-Burton Richard (SOUTH LONDON HEALTHCARE NHS TRUST) |
Thu, 26 Jul 2012 15:57:01 +0100 |
287 lines |
Cholesterol testing in GP surgeries
|
Czarnota, Alison |
Thu, 26 Jul 2012 16:18:11 +0100 |
185 lines |
Re: Cholesterol testing in GP surgeries
|
David James |
Thu, 26 Jul 2012 15:20:27 +0000 |
317 lines |
Re: Cholesterol testing in GP surgeries
|
Jonathan Kay |
Thu, 26 Jul 2012 16:26:24 +0100 |
145 lines |
Re: Cholesterol testing in GP surgeries
|
Barlow Ian (NORTHERN LINCOLNSHIRE AND GOOLE HOSPITALS NHS FOUNDATION TRUST) |
Thu, 26 Jul 2012 16:49:40 +0100 |
408 lines |
Re: Cholesterol testing in GP surgeries
|
Jonathan Kay |
Thu, 26 Jul 2012 17:07:37 +0100 |
340 lines |
automated bilirubin assay for CSF bilirubin
|
Dr Peadar McGing |
Fri, 27 Jul 2012 08:36:03 +0100 |
47 lines |
? sensitivity to sulphonamides
|
Louise Ward |
Fri, 27 Jul 2012 09:30:25 +0100 |
61 lines |
Re: ? sensitivity to sulphonamides
|
Jonathan Kay |
Fri, 27 Jul 2012 08:36:10 +0000 |
49 lines |
Re: automated bilirubin assay for CSF bilirubin
|
Rafaq Azad |
Fri, 27 Jul 2012 11:42:00 +0000 |
109 lines |
Intra-operative PTH
|
Smith Sophy - Clinical Scientist |
Fri, 27 Jul 2012 13:15:34 +0100 |
141 lines |
Assessing reagent lot to lot variation
|
Douglas Thompson |
Fri, 27 Jul 2012 13:25:18 +0100 |
49 lines |
Re: pregnancy related reference ranges - Roche systems
|
birminghamquality |
Fri, 27 Jul 2012 13:42:55 +0100 |
354 lines |
Re: Assessing reagent lot to lot variation
|
Indovina, Joe [OCDUS] |
Fri, 27 Jul 2012 09:24:27 -0400 |
89 lines |
Clinical Scientist Post Fixed Term 12 months at GSTS Pathology
|
Dowley Michaela (Nee Glynn) |
Fri, 27 Jul 2012 16:31:54 +0100 |
404 lines |
ACB Spotlight Meeting update
|
Graham Groom |
Mon, 30 Jul 2012 06:50:09 +0100 |
1119 lines |
Clinical Chemistry Comments
|
sutirtha chakraborty |
Mon, 30 Jul 2012 13:09:32 +0530 |
79 lines |
Betr.: Clinical Chemistry Comments
|
Wytze Oosterhuis |
Mon, 30 Jul 2012 10:59:39 +0200 |
120 lines |
journals
|
Mainwaring-Burton Richard (SOUTH LONDON HEALTHCARE NHS TRUST) |
Mon, 30 Jul 2012 14:44:02 +0100 |
262 lines |
Re: journals
|
Graham, Billy |
Mon, 30 Jul 2012 16:30:34 +0100 |
334 lines |
Re: journals
|
Mainwaring-Burton Richard (SOUTH LONDON HEALTHCARE NHS TRUST) |
Mon, 30 Jul 2012 16:40:46 +0100 |
517 lines |
Glucose load
|
Robinson Paul |
Mon, 30 Jul 2012 17:35:24 +0100 |
253 lines |
Order-comms and clinical details
|
Anna Barton |
Tue, 31 Jul 2012 12:07:45 +0100 |
182 lines |